calcium gluconate has been researched along with cysteine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dinu, I; Dinu, R | 2 |
| Anderson, C; MacKay, M | 2 |
| de Jesús Escalante-Padrón, F; de Jesús López-López, E; Hurtado-Torres, GF; Lima-Rogel, V; Romano-Moreno, S | 1 |
| Christensen, JM; Heisel, CF; Huston, RK; Minc, L; Vermillion, BR | 2 |
| Christensen, JM; Heisel, CF; Huston, RK; Minc, L; Mohamed, SM; Sawyer, T; Stout, KN | 1 |
2 trial(s) available for calcium gluconate and cysteine
| Article | Year |
|---|---|
Chelatotherapy in multiple sclerosis. Open preliminary study of a new therapeutical principle applied in multiple sclerosis--public health topic.
Topics: Adult; Animals; Calcium Gluconate; Chelating Agents; Chronic Disease; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Evaluation, Preclinical; Edetic Acid; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Rats; T-Lymphocytes; Time Factors | 1985 |
Herpes zoster and herpes simplex--public health matter; chelatotherapy in these acute neuroviroses.
Topics: Animals; Antiviral Agents; Calcium Gluconate; Chelating Agents; Chronic Disease; Clinical Trials as Topic; Cysteine; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Edetic Acid; Female; Herpes Simplex; Herpes Zoster; Humans; Male; Rats; Recurrence; Time Factors | 1984 |
6 other study(ies) available for calcium gluconate and cysteine
| Article | Year |
|---|---|
Physical Compatibility of Sodium Glycerophosphate and Calcium Gluconate in Pediatric Parenteral Nutrition Solutions.
Topics: Calcium; Calcium Gluconate; Chemical Precipitation; Cysteine; Dose-Response Relationship, Drug; Glycerophosphates; Hydrogen-Ion Concentration; Parenteral Nutrition Solutions; Phosphates; Phosphorus; Solubility; Vitamins | 2015 |
Aluminum Contamination in Parenteral Nutrition Admixtures for Low-Birth-Weight Preterm Infants in Mexico.
Topics: Aluminum; Calcium Gluconate; Carnitine; Cysteine; Drug Contamination; Humans; Infant; Infant, Low Birth Weight; Infant, Premature; Mexico; Nutritional Requirements; Parenteral Nutrition Solutions; Phosphates; Potassium Compounds; United States; United States Food and Drug Administration | 2016 |
Physical Compatibility of Calcium Chloride and Sodium Glycerophosphate in Pediatric Parenteral Nutrition Solutions.
Topics: Amino Acids; Calcium Chloride; Calcium Gluconate; Child; Cysteine; Glycerophosphates; Humans; Hydrogen-Ion Concentration; Parenteral Nutrition Solutions; Phosphates; Solubility | 2016 |
Aluminum Content of Neonatal Parenteral Nutrition Solutions.
Topics: Aluminum; Calcium Chloride; Calcium Gluconate; Cysteine; Glycerophosphates; Parenteral Nutrition Solutions; Phosphates; United States; United States Food and Drug Administration | 2017 |
Aluminum Content of Neonatal Parenteral Nutrition Solutions: Options for Reducing Aluminum Exposure.
Topics: Aluminum; Calcium Chloride; Calcium Gluconate; Cysteine; Glycerophosphates; Humans; Infant, Newborn; Parenteral Nutrition Solutions; Phosphates; United States | 2017 |
High particle counts in neonatal parenteral nutrition solutions with added cysteine: Relationship to crystal formation and effect of filtration on cysteine content.
Topics: Amino Acids; Calcium Chloride; Calcium Gluconate; Cysteine; Humans; Infant, Newborn; Parenteral Nutrition Solutions | 2022 |